I am a physician, immunologist, and molecular biologist with over 30 years of global leadership experience in biopharmaceutical industry, clinical research and development, translational medicine, business development, and medical affairs. Former Chief Medical Officer at Mirror Biologics, conducting a Phase IIB pre-registration study in refractory metastatic colorectal cancer; a Phase II/III randomized, controlled study in advanced, metastatic liver cancer; and a Phase I/II clinical study in healthy adults over 65 yo as a universal anti-respiratory viral vaccine. Former Chief Medical Officer at ASC Therapeutics Therapeutics, a clinical-stage biopharma company developing gene, CRISPR and cell therapies for monogenic diseases and immuno-oncology. Executive contributor to public/private financings, IPOs, mergers, and acquisitions.My mission is to translate cutting-edge science into innovative and life-changing therapies for patients with unmet medical needs. My field of expertise covers immuno-oncology, allogeneic cell therapies (AlloStim® and Decidua Stromal Cells), autologous (CAR-T), gene therapy, gene editing, CRISPR, biologic therapies (HUMIRA), personalized medicine, genomic and cellular biomarkers, and other therapeutic areas such as oncology, hematology, autoimmunity-inflammation, rheumatology, neurology, cardiovascular, rare and metabolic diseases. I also leverage my extensive network and knowledge as the Executive Director at Medic Affairs Consulting LLC, and Executive Advisor at SSI Strategy, providing strategic advice and guidance to biotech and pharma companies, investors, and academia. I am passionate about advancing the science and practice of medicine, and sharing my insights and experience through keynote speeches, best-selling books, peer-reviewed publications, and media appearances.